Polyethylene Glycol 3350 Powder, For Solution
FDA Label NDC 55154-2328

17 label sections · Submitted to the FDA by Cardinal Health 107, Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Cardinal Health 107, Llc for the product Polyethylene Glycol 3350 (NDC 55154-2328). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient (in each dose), purpose, use, warnings, do not use, ask a doctor before use if you have, ask a doctor or pharmacist before use if you are, when using this product, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Generic Section

TAMPER-EVIDENT: DO NOT USE IF
FOIL IS OPEN OR BROKEN

*This product is not manufactured or distributed by Bayer HealthCare LLC,
owner of the registered trademark MiraLAX®.

Distributed by MAJOR® PHARMACEUTICALS
Indianapolis, IN 46268
www.majorpharmaceuticals.com

Distributed By:

Cardinal Health

Dublin, OH 43017

L56770670124


Rev. 03/22                             M-17                              Re-order No. 701066

Product of India                                                      50844      REV0222D72648

Principal Display Panel

NDC 55154-2328-5

PEG3350

Polyethylene Glycol 3350

Powder for Oral Solution, Osmotic Laxative

7-Packets NET WT 0.5 OZ (17 g) EACH

100% Bag Label (D804d78d Bf7c 4ae2 A3a7 D1e7337bbeb8 00)

100% Bag Label (D804d78d Bf7c 4ae2 A3a7 D1e7337bbeb8 00)

* Please review the disclaimer below.